Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells
Open Access
- 1 July 2007
- journal article
- Published by American Society of Hematology in Blood
- Vol. 110 (1) , 186-192
- https://doi.org/10.1182/blood-2006-12-062422
Abstract
Expression of the PD-1 receptor on T cells has been shown to provide an important inhibitory signal that down-modulates peripheral effector responses in normal tissues and tumors. Furthermore, PD-1 up-regulation on chronically activated T cells can maintain them in a partially reversible inactive state. The function of PD-1 in the very early stages of T-cell response to antigen in vivo has not been fully explored. In this study, we evaluate the role of PD-1 and its 2 B7 family ligands, B7-H1 (PD-L1) and B7-DC (PD-L2), in early fate decisions of CD8 T cells. We show that CD8 T cells specific for influenza hemagglutinin (HA) expressed as a self-antigen become functionally tolerized and express high levels of surface PD-1 by the time of their first cell division. Blockade of PD-1 or B7-H1, but not B7-DC, at the time of self-antigen encounter mitigates tolerance induction and results in CD8 T-cell differentiation into functional cytolytic T lymphocytes (CTLs). These findings demonstrate that, in addition to modulating effector functions in the periphery, B7-H1:PD-1 interactions regulate early T-cell–fate decisions.Keywords
This publication has 33 references indexed in Scilit:
- In vivo costimulatory role of B7-DC in tuning T helper cell 1 and cytotoxic T lymphocyte responsesThe Journal of Experimental Medicine, 2005
- THE B7 FAMILY REVISITEDAnnual Review of Immunology, 2005
- Peripheral Tolerance of CD8 T LymphocytesImmunity, 2005
- Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4Nature Immunology, 2005
- Co-inhibitory molecules of the B7–CD28 family in the control of T-cell immunityNature Reviews Immunology, 2004
- Transient gain of effector function by CD8+ T cells undergoing peripheral tolerance to high-dose self-antigenEuropean Journal of Immunology, 2004
- Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient MiceScience, 2001
- The Emerging Role of CTLA-4 as an Immune AttenuatorImmunity, 1997
- Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4Science, 1995
- Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4Immunity, 1995